By Cristal Cody
Tupelo, Miss., Sept. 28 – GlaxoSmithKline Capital plc priced $1.25 billion of 0.534% guaranteed notes due Oct. 1, 2023 (A2/A) on Monday at par to yield a spread of 38 basis points over Treasuries, according to an FWP filing with the Securities and Exchange Commission.
Bookrunners were BofA Securities Inc., Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC and Morgan Stanley & Co. LLC.
The bonds are guaranteed by parent company GlaxoSmithKline plc.
Proceeds will be used to redeem the company’s 3.125% notes due 2021 and for general corporate purposes.
GlaxoSmithKline Capital is a financing arm of the Brentford, England-based pharmaceuticals and consumer health products company.
The global health care company for pharmaceuticals and consumer health products has its U.S. headquarters in Wilmington, Del.
| Issuer: | GlaxoSmithKline Capital plc
|
| Guarantor: | GlaxoSmithKline plc
|
| Amount: | $1.25 billion
|
| Maturity: | Oct. 1, 2023
|
| Description: | Notes
|
| Bookrunners: | BofA Securities Inc., Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC and Morgan Stanley & Co. LLC
|
| Co-managers: | Barclays, BNP Paribas Securities Corp., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc., J.P. Morgan Securities LLC, Mizuho Securities USA LLC and Standard Chartered Bank
|
| Call features: | Make-whole call at Treasuries plus 10 bps before Oct. 1, 2022; thereafter at par
|
| Coupon: | 0.534%
|
| Price: | Par
|
| Yield: | 0.534%
|
| Spread: | Treasuries plus 38 bps
|
| Trade date: | Sept. 28
|
| Settlement date: | Oct. 1
|
| Ratings: | Moody’s: A2
|
| S&P: A
|
| Distribution: | SEC registered
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
